This study aims to compare two different multimodal analgesic techniques for pain management after total knee arthroplasty (TKA). The primary purpose is to determine if a combination of two specific nerve blocks administered by an anesthesiologist (Femoral Triangle Block + iPACK block) results in superior pain control compared to a combination of a nerve block and a local infiltration administered by the surgeon (FTB + Periarticular Infiltration \[PAI\]). The hypothesis is that the FTB + iPACK combination will lead to a significant reduction in Numeric Rating Scale (NRS) pain scores with movement at 24 hours postoperatively. This will be a prospective, randomized, double-blind, parallel-group, single-center study involving patients scheduled for primary unilateral TKA. Participants will be randomly assigned to one of two groups. All patients, clinicians (anesthesiologists and surgeon), and outcome assessors will be blinded to the group allocation using a double-dummy technique.
Total knee arthroplasty (TKA) is a highly successful procedure for end-stage knee osteoarthritis but is associated with significant postoperative pain. Effective pain management is crucial for facilitating early rehabilitation and improving patient comfort. Modern pain management relies on multimodal, opioid-sparing protocols that often include motor-sparing regional anesthesia techniques like the femoral triangle block (FTB). While FTB provides excellent analgesia for the anterior part of the knee, pain originating from the posterior knee capsule remains a significant challenge. This posterior pain is commonly managed either by the surgeon through a diffuse periarticular infiltration (PAI) of a local anesthetic cocktail or by the anesthesiologist through a targeted, ultrasound-guided block of the posterior capsule known as the iPACK block. It is currently unclear whether a fully anesthesiologist-driven, neuroanatomically targeted approach (FTB + iPACK) offers superior outcomes compared to a hybrid approach involving both the anesthesiologist and the surgeon (FTB + PAI). This prospective, randomized, double-blind controlled trial is designed to compare these two advanced analgesic combinations. All patients will receive a standardized spinal anesthetic (3 mL of 0.5% heavy bupivacaine). The study will evaluate which method provides better pain control, measured primarily by Numeric Rating Scale (NRS) pain scores at 24 hours, and secondarily by total rescue analgesic (tramadol) consumption, functional recovery (Timed Up and Go test and Straight Leg Raise test), and knee range of motion. Sample size will be determined based on an internal pilot study. An initial 30 patients (15 per group) will be enrolled. The mean and standard deviation of the primary outcome (NRS pain score with movement at 24 hours) from this pilot cohort will be used to calculate the final sample size required to detect a clinically significant difference (e.g., 1 point on the NRS) with 80% power and an alpha of 0.05. The final enrollment target is estimated to be approximately 100 patients (50 per group) to account for potential dropouts.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
100
All patients will receive an ultrasound-guided Femoral Triangle Block (FTB) with 20 mL of 0.25% Bupivacaine, supplemented by an Anterior Femoral Cutaneous Nerve block with 5 mL of the same solution.
Patients will receive an ultrasound-guided real iPACK block with 20 mL of 0.25% Bupivacaine
Patients will receive a sham Periarticular Infiltration (PAI) with an equivalent volume of normal saline intraoperatively.
Patients will receive a sham iPACK block with an equivalent volume of normal saline preoperatively.
The surgeon intraoperatively administers the standardized PAI cocktail (total volume approx. 50 mL): 24 mL 0.5% Bupivacaine, 0.3 mL Adrenaline (1:1000), 40 mg Methylprednisolone, 1 gr Cefazoline, and 22 mL 0.9% Sodium Chloride. The surgeon will administer the infiltration into the medial, lateral, and posterior quadrants of the knee capsule, specifically sparing the anterior quadrant.
Used for FTB and iPACK blocks.
Used for PAI
Used for sham/placebo infiltration or block.
Postoperative Pain Score with Movement at 24 Hours
Pain assessed via Numeric Rating Scale (NRS) during active movement (e.g., active knee flexion or straight leg raise). Scale: 0 (no pain) to 10 (worst pain imaginable).
Time frame: 24 and 48. hours postoperatively
Postoperative Pain Scores (Time-Course)
Numeric Rating Scale (NRS) for pain (0-10) assessed at rest and with movement.
Time frame: Assessed at 6, 12, and 24 hours postoperatively
Time to First Rescue Analgesia
Time (in minutes) from the end of surgery to the first patient request for rescue tramadol.
Time frame: First 48 postoperative hours
Time Up to Go Test
The time taken (in seconds) for the participant to stand up from a standard armchair, walk a distance of 3 meters, turn, walk back to the chair, and sit down. Lower values indicate better functional mobility.
Time frame: Assessed at 24 hours
Straight Leg Raise
Assessment of active quadriceps motor function. Defined as the participant's ability to actively lift the operated leg off the bed with the knee fully extended (straight). This will be assessed as a binary outcome (Success = Able to lift unassisted / Failure = Unable to lift).
Time frame: Postoperative 24. hour
Knee Range of Motion (ROM)
Active knee flexion (in degrees)
Time frame: Baseline (Preoperative) and 24 hours postoperatively
Incidence of Adverse Events
Incidence of postoperative nausea and vomiting (PONV).
Time frame: First 48 hours.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.